NCT00338429

Brief Summary

The purpose of the Strongest Families (formerly Family Help Program)is to evaluate the effectiveness of the Strongest Families distance intervention compared to usual or standard care that is typically provided to children with mild to moderate sleep onset latency and/or bedtime resistance difficulties. This is a single-centre trial based at the IWK Health Centre. The primary outcome is change in sleep patterns (sleep onset latency and/or bedtime resistance).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Apr 2005

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2005

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 15, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 20, 2006

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
Last Updated

September 2, 2016

Status Verified

September 1, 2016

Enrollment Period

4.1 years

First QC Date

June 15, 2006

Last Update Submit

September 1, 2016

Conditions

Keywords

sleep onset latencybedtime resistance

Outcome Measures

Primary Outcomes (1)

  • Child Sleep Habits Questionnaire

    baseline, 2months (end of treatment) & 6 month follow-up

Secondary Outcomes (6)

  • Sleep diary

    daily during treatment; on follow-up at 2 & 6 MONTHS post randomization

  • Actigraph recordings

    daily during treatment; baseline, 2 & 6 months follow-up

  • Child Behaviour Checklist (CBCL)

    baseline, 2months (end of treatment) & 6 month follow-up

  • Satisfaction scale (researcher developed)

    end of treatment

  • Parenting Stress Index

    baseline, 2months (end of treatment) & 6 month follow-up

  • +1 more secondary outcomes

Study Arms (2)

Treatment: FHP Sleep Program

EXPERIMENTAL

Stratified with or without behavior Disorder Diagnosis (ADHD): 50% randomized to receive Better Days, Better Nights- sleep distance intervention

Behavioral: FHP Sleep Program

Control: Usual Care

NO INTERVENTION

Stratified with/without behavior diagnosis (ADHD): 50% randomized to receive usual care for sleep disorder

Interventions

Cognitive-Behavioral Intervention

Treatment: FHP Sleep Program

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • children 5-12 years of age
  • attending grades primary-6 (Elementary School)
  • sleep onset latency and/or bedtime resistance
  • speak and write English
  • provides parental authorization
  • has access to telephone in home

You may not qualify if:

  • neurological conditions
  • moderate to severe cognitive impairment
  • has received a behavioral intervention for sleep difficulties in the past 6 months
  • nocturnal enuresis
  • sleep apnea
  • co-sleeping

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IWK Health Centre

Halifax, Nova Scotia, B3K 6R8, Canada

Location

Related Publications (1)

  • Corkum P, Lingley-Pottie P, Davidson F, McGrath P, Chambers CT, Mullane J, Laredo S, Woodford K, Weiss SK. Better Nights/Better Days-Distance Intervention for Insomnia in School-Aged Children With/Without ADHD: A Randomized Controlled Trial. J Pediatr Psychol. 2016 Jul;41(6):701-13. doi: 10.1093/jpepsy/jsw031. Epub 2016 May 16.

    PMID: 27189687BACKGROUND

MeSH Terms

Conditions

Sleep Wake Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Penny Corkum, PhD.

    IWK Health Centre and Dalhousie University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2006

First Posted

June 20, 2006

Study Start

April 1, 2005

Primary Completion

May 1, 2009

Study Completion

May 1, 2009

Last Updated

September 2, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Aggregate summary data would be made available but not individual data.

Locations